Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Bruce J Roth

1PUBLICATIONS

12CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Mar 30, 2023

Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial).

Michael J Morris, Glenn Heller, David W Hillman

Pageof 1

Frequent Collaborators

1 joint publications

Michael J Morris

1 joint publications

David W Hillman

1 joint publications

Olivia Bobek

1 joint publications

Emmanuel S Antonarakis

1 joint publications

Alan H Bryce

1 joint publications

Himisha Beltran

1 joint publications

Andrew J Armstrong

1 joint publications

Jan H Beumer

1 joint publications

Amir Goldkorn

1 joint publications

Han Xiao

Frequent Collaborators

1 joint publications

Michael J Morris

1 joint publications

David W Hillman

1 joint publications

Olivia Bobek

1 joint publications

Emmanuel S Antonarakis

Top Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

See more related videos

Top Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

See more related videos